Llinas-Brunet; Montse
Patent Applications and Registrations
Patent applications and USPTO patent grants for Llinas-Brunet; Montse.The latest application filed is for "viral polymerase inhibitors".
Company Profile
0.36.33
- Llinas-Brunet; Montse - Dollard-des-Ormeaux CA
- Llinas-Brunet; Montse - Laval CA
- Llinas-Brunet; Montse - Dollards des Ormeaux CA
- Llinas-Brunet; Montse - D. D. O. CA
- Llinas-Brunet; Montse - Pierrefonds CA
Patent Activity
| Patent | Date |
|---|---|
| Viral polymerase inhibitors Grant 8,912,182 - Beaulieu , et al. December 16, 2 | 2014-12-16 |
| Viral Polymerase Inhibitors App 20130331391 - BEAULIEU; Pierre L. ; et al. | 2013-12-12 |
| Viral polymerase inhibitors Grant 8,541,402 - Beaulieu , et al. September 24, 2 | 2013-09-24 |
| Viral polymerase inhibitors Grant 8,476,257 - Beaulieu , et al. July 2, 2 | 2013-07-02 |
| Hepatitis C Inhibitor Compounds App 20120269769 - LLINAS-BRUNET; Montse ; et al. | 2012-10-25 |
| Viral Polymerase Inhibitors App 20120214783 - BEAULIEU; Pierre L. ; et al. | 2012-08-23 |
| Hepatitis C Inhibitor Compounds App 20120077737 - Llinas-Brunet; Montse ; et al. | 2012-03-29 |
| Hepatitis C Inhibitor Compounds App 20120034187 - LLINAS-BRUNET; Montse ; et al. | 2012-02-09 |
| Hepatitis C Inhibitor Compounds App 20110294778 - LLINAS-BRUNET; Montse ; et al. | 2011-12-01 |
| Hepatitis C inhibitor compounds Grant 8,067,438 - Llinas-Brunet , et al. November 29, 2 | 2011-11-29 |
| Hepatitis C Inhibitor Compounds App 20110177030 - LLINAS-BRUNET; Montse ; et al. | 2011-07-21 |
| Hepatitis C inhibitor compounds Grant 7,939,667 - Llinas-Brunet , et al. May 10, 2 | 2011-05-10 |
| Hepatitis C inhibitor tri-peptides Grant RE42,164 - Llinas-Brunet , et al. February 22, 2 | 2011-02-22 |
| Viral Polymerase Inhibitors App 20110021486 - Beaulieu; Pierre L. ; et al. | 2011-01-27 |
| Hepatitis C inhibitor tri-peptides Grant RE41,894 - Llinas-Brunet , et al. October 26, 2 | 2010-10-26 |
| Hepatitis C inhibitor dipeptide analogs Grant 7,767,818 - Bailey , et al. August 3, 2 | 2010-08-03 |
| Macrocyclic peptides active against the hepatitis C virus Grant 7,749,961 - Llinas-Brunet , et al. July 6, 2 | 2010-07-06 |
| Hepatitis C inhibitor tri-peptides Grant RE41,356 - Llinas-Brunet , et al. May 25, 2 | 2010-05-25 |
| Hepatitis C inhibitor peptide analogs Grant 7,705,146 - Bailey , et al. April 27, 2 | 2010-04-27 |
| Hepatitis C inhibitor peptide analogs Grant 7,696,242 - Bailey , et al. April 13, 2 | 2010-04-13 |
| Inhibitors of Hepatitis C NS3 Protease App 20100087382 - Bailey; Murray D. ; et al. | 2010-04-08 |
| Macrocyclic Peptides Active Against The Hepatitis C Virus App 20100028300 - LLINAS-BRUNET; Montse ; et al. | 2010-02-04 |
| Macrocyclic peptides active against the hepatitis C virus Grant 7,642,235 - Llinas-Brunet , et al. January 5, 2 | 2010-01-05 |
| Macrocyclic Peptides Active Against The Hepatitis C Virus App 20090264346 - LLINAS-BRUNET; Montse ; et al. | 2009-10-22 |
| Hepatitis C inhibitor compounds Grant 7,585,845 - Llinas-Brunet , et al. September 8, 2 | 2009-09-08 |
| Hepatitis C Inhibitor Dipeptide Analogs App 20090156822 - BAILEY; Murray D. ; et al. | 2009-06-18 |
| Hepatitis C inhibitor dipeptide analogs Grant 7,511,157 - Bailey , et al. March 31, 2 | 2009-03-31 |
| Macrocyclic peptides active against the hepatitis C virus Grant 7,504,378 - Llinas-Brunet , et al. March 17, 2 | 2009-03-17 |
| Hepatitis C inhibitor tri-peptides Grant RE40,525 - Llinas-Brunet , et al. September 30, 2 | 2008-09-30 |
| Hepatitis C Inhibitor Peptide Analogs App 20080200497 - Bailey; Murray D. ; et al. | 2008-08-21 |
| Hepatitis C Inhibitor Compounds App 20070243166 - LLINAS-BRUNET; Montse ; et al. | 2007-10-18 |
| Hepatitis c inhibitor peptide analogs App 20060258868 - Bailey; Murray D. ; et al. | 2006-11-16 |
| Macrocyclic peptides active against the hepatitis C virus Grant 7,119,072 - Llinas-Brunet , et al. October 10, 2 | 2006-10-10 |
| Hepatitis C inhibitor tri-peptides Grant 7,091,184 - Llinas-Brunet , et al. August 15, 2 | 2006-08-15 |
| Macrocyclic peptides active against the hepatitis C virus App 20060089300 - Llinas-Brunet; Montse ; et al. | 2006-04-27 |
| Hepatitis C inhibitor dipeptide analogs App 20060046965 - Bailey; Murray D. ; et al. | 2006-03-02 |
| Hepatitis C inhibitor peptide analogs App 20060019905 - Bailey; Murray D. ; et al. | 2006-01-26 |
| Macrocyclic peptides active against the hepatitis C virus App 20050192212 - Llinas-Brunet, Montse ; et al. | 2005-09-01 |
| Hepatitis C inhibitor compound Grant 6,919,423 - Llinas-Brunet July 19, 2 | 2005-07-19 |
| Hepatitis C inhibitor peptide analogs Grant 6,908,901 - Bailey , et al. June 21, 2 | 2005-06-21 |
| Macrocyclic peptides active against the hepatitis C virus App 20050080005 - Llinas-Brunet, Montse ; et al. | 2005-04-14 |
| Macrocyclic peptides active against the hepatitis C virus App 20050075279 - Llinas-Brunet, Montse ; et al. | 2005-04-07 |
| Hepatitis C inhibitor compounds App 20050020503 - Llinas-Brunet, Montse ; et al. | 2005-01-27 |
| Hepatitis C inhibitor compound App 20040229818 - Llinas-Brunet, Montse | 2004-11-18 |
| Hepatitis C inhibitor peptide analogs App 20040224900 - Bailey, Murray D. ; et al. | 2004-11-11 |
| Hepatitis C inhibitor peptides Grant 6,767,991 - Llinas-Brunet , et al. July 27, 2 | 2004-07-27 |
| Macrocyclic peptides active against the hepatitis C virus App 20040002448 - Tsantrizos, Youla S. ; et al. | 2004-01-01 |
| Macrocyclic peptides active against the hepatitis C virus App 20030224977 - Llinas-Brunet, Montse ; et al. | 2003-12-04 |
| Hepatitis C inhibitor tri-peptides Grant 6,642,204 - Llinas-Brunet , et al. November 4, 2 | 2003-11-04 |
| Hepatitis C inhibitor tri-peptides App 20030191067 - Llinas-Brunet, Montse ; et al. | 2003-10-09 |
| Hepatitis C inhibitor tri-peptides App 20030186895 - Llinas-Brunet, Montse ; et al. | 2003-10-02 |
| Hepatitis C inhibitor tri-peptides App 20030187018 - Llinas-Brunet, Montse ; et al. | 2003-10-02 |
| Macrocyclic peptides active against the hepatitis C virus App 20030181363 - Llinas-Brunet, Montse ; et al. | 2003-09-25 |
| Macrocyclic peptides active against the hepatitis C virus Grant 6,608,027 - Tsantrizos , et al. August 19, 2 | 2003-08-19 |
| Hepatitis C inhibitor tri-peptides Grant 6,534,523 - Llinas-Brunet , et al. March 18, 2 | 2003-03-18 |
| Hepatitis C inhibitor tri-peptides Grant 6,420,380 - Llinas-Brunet , et al. July 16, 2 | 2002-07-16 |
| Hepatitis C inhibitor tri-peptides Grant 6,410,531 - Llinas-Brunet , et al. June 25, 2 | 2002-06-25 |
| Hepatitis C inhibitor tri-peptides App 20020037998 - Llinas-Brunet, Montse ; et al. | 2002-03-28 |
| Hepatitis C inhibitor tri-peptides App 20020016442 - Llinas-brunet, Montse ; et al. | 2002-02-07 |
| Hepatitis C inhibitor tri-peptides Grant 6,329,379 - Llinas-Brunet , et al. December 11, 2 | 2001-12-11 |
| Hepatitis C inhibitor tri-pepitides Grant 6,329,417 - Llinas-Brunet , et al. December 11, 2 | 2001-12-11 |
| Hepatitis C inhibitor tri-peptides Grant 6,323,180 - Llinas-Brunet , et al. November 27, 2 | 2001-11-27 |
| Src family SH2 domain inhibitors Grant 6,268,365 - Betageri , et al. July 31, 2 | 2001-07-31 |
| Hepatitis C inhibitor peptide analogues Grant 6,143,715 - Llinas-Brunet , et al. November 7, 2 | 2000-11-07 |
| Src family SH2 domain inhibitors Grant 6,054,470 - Betageri , et al. April 25, 2 | 2000-04-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 